(PharmaNewsWire.Com, March 13, 2018 ) The Global Acute Ischemic Stroke Treatment and Diagnosis Market was worth $1814 million in 2015 and estimated to be growing at a CAGR of 6.7%, to reach $2508 million by 2020. Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to lack of blood supply to the brain.
Rising prevalence of acute ischemia stroke cases are driving the global demand for surgical procedures in acute stroke treatment. Technological advancements in surgical procedures along with rising aging population, increased demand for minimally invasive procedures and growth in healthcare spending are the other major factors driving the growth of Global Acute Ischemic Stroke diagnosis and treatment market on the other side excessive usage of medication for the treatment of ischemic stroke and high cost of surgical procedures are hindering the growth of the market.
Global Acute Ischemic Stroke Diagnosis and Treatment Market is segmented into Diagnostic type and Surgery type. On the basis of Diagnostic type the market is further sub-segmented into Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Cerebral angiography and nuclear imaging. Based on Surgery Type the market is segmented into Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy. Carotid Endarterectomy is the largest segment accounting for a share of approximately XX% and is expected to maintain its strong share owing to high success rate, short treatment duration and easy availability.
On the Basis of geography global Acute Ischemic Stroke Diagnosis and Treatment Market is segmented into North America, Europe, Asia-Pacific, Latin America and Africa & Middle-East. North America is the largest market for Acute Ischemic Stroke Diagnosis and Treatment devices accounting for a share of approximately XX% in 2015 and is estimated to continue its strong hold of the market owing to favourable government initiatives, technological innovations and increasing demand for ischemic stroke products. Asia-Pacific is estimated to be a hopeful market for acute ischemic stroke diagnosis owing to increasing incidence of ischemic stroke cases in the region. Manufacturers are expanding their operations in Asia-Pacific region as these regions hold immense potential for the market growth
Some of the major companies covered in the report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillsets dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
